Ann: DurAVR valve patient outcomes exceed expectations, page-50

Yep the more I looked the more I found on this one
perhaps you need a fresh set of eyes
dont worry I will go away and leave the blinded to blow smoke ... to each other
what is forum if you can properly debate the actual facts

Cardiocel has proven not calcium free in aortic valves
The AVR TAVR is very very early stage with many years of testing required(and risk it wont work) to prove anything that would be commercial
Perhaps management are over paid for such a low MC and actual performance is very poor.
CEO looks like a good presenter but no real depth other than trying to hype. I looked back and saw the motorbike tweets, Bit insulting dont you think to people who have lost money
Competitors will not wait around to see what happens here . They have their own R+D process and own versions of adapt which are working
will need another 300 million at least to get anything commercial

onto Osteopore now